name: Transfusion of Autologous Bone Marrow into Central Vein, Percutaneous Approach


name: Transfusion of Autologous Whole Blood into Central Vein, Percutaneous Approach


name: Transfusion of Nonautologous Whole Blood into Central Vein, Percutaneous Approach


name: Transfusion of Autologous Serum Albumin into Central Vein, Percutaneous Approach


name: Transfusion of Nonautologous Serum Albumin into Central Vein, Percutaneous Approach


name: Transfusion of Autologous Frozen Plasma into Central Vein, Percutaneous Approach


name: Transfusion of Nonautologous Frozen Plasma into Central Vein, Percutaneous Approach


name: Transfusion of Autologous Fresh Plasma into Central Vein, Percutaneous Approach


name: Transfusion of Nonautologous Fresh Plasma into Central Vein, Percutaneous Approach


name: autologous transfusion of plasma cryoprecipitate into central vein, percutaneous approach


name: nonautologous transfusion of plasma cryoprecipitate into central vein, percutaneous approach


name: Transfusion of Autologous Red Blood Cells into Central Vein, Percutaneous Approach


name: Transfusion of Nonautologous Red Blood Cells into Central Vein, Percutaneous Approach


name: Transfusion of Autologous Frozen Red Cells into Central Vein, Percutaneous Approach


name: Transfusion of Nonautologous Frozen Red Cells into Central Vein, Percutaneous Approach


name: Transfusion of Autologous White Cells into Central Vein, Percutaneous Approach


name: Transfusion of Nonautologous White Cells into Central Vein, Percutaneous Approach


name: Transfusion of Autologous Platelets into Central Vein, Percutaneous Approach


name: Transfusion of Nonautologous Platelets into Central Vein, Percutaneous Approach


name: Transfusion of Autologous Globulin into Central Vein, Percutaneous Approach


name: Transfusion of Nonautologous Globulin into Central Vein, Percutaneous Approach


name: transfusion of autologous fibrinogen into central vein, percutaneous approach


name: transfusion of nonautologous fibrinogen into central vein, percutaneous approach


name: transfusion of autologous antihemophilic factors into central vein, percutaneous approach


name: transfusion of nonautologous antihemophilic factors into central vein, percutaneous approach


name: autologous transfusion of factor IX into central vein, percutaneous approach


name: nonautologous transfusion of factor IX into central vein, percutaneous approach


name: Transfusion of Autologous Cord Blood Stem Cells into Central Vein, Percutaneous Approach


name: Transfusion of Autologous Hematopoietic Stem Cells into Central Vein, Percutaneous Approach


name: Transfusion of Nonautologous Whole Blood into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous Serum Albumin into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous Frozen Plasma into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous Fresh Plasma into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous Plasma Cryoprecipitate into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous Red Blood Cells into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous Frozen Red Cells into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous White Cells into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous Platelets into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous Globulin into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous Fibrinogen into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous Antihemophilic Factors into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous Factor IX into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous Whole Blood into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Transfusion of Nonautologous Serum Albumin into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Transfusion of Nonautologous Frozen Plasma into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Transfusion of Nonautologous Fresh Plasma into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Transfusion of Nonautologous Plasma Cryoprecipitate into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Transfusion of Nonautologous Red Blood Cells into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Transfusion of Nonautologous Frozen Red Cells into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Transfusion of Nonautologous White Cells into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Transfusion of Nonautologous Platelets into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Transfusion of Nonautologous Globulin into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Transfusion of Nonautologous Fibrinogen into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Transfusion of Nonautologous Antihemophilic Factors into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Transfusion of Nonautologous Factor IX into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Irrigation of Indwelling Device using Irrigating Substance, External Approach


name: Introduction of Other Antineoplastic into Skin and Mucous Membranes, External Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Skin and Mucous Membranes, External Approach


name: Introduction of Oxazolidinones into Skin and Mucous Membranes, External Approach


name: Introduction of Other Anti-infective into Skin and Mucous Membranes, External Approach


name: Introduction of Anti-inflammatory into Skin and Mucous Membranes, External Approach


name: Introduction of Serum, Toxoid and Vaccine into Skin and Mucous Membranes, External Approach


name: Introduction of Anesthetic Agent into Skin and Mucous Membranes, External Approach


name: Introduction of Other Therapeutic Substance into Skin and Mucous Membranes, External Approach


name: Introduction of Other Diagnostic Substance into Skin and Mucous Membranes, External Approach


name: Introduction of Pigment into Skin and Mucous Membranes, External Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Skin and Mucous Membranes, External Approach


name: Introduction of Destructive Agent into Skin and Mucous Membranes, External Approach


name: Introduction of Other Antineoplastic into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Oxazolidinones into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Other Anti-infective into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Anti-inflammatory into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Serum, Toxoid and Vaccine into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Nutritional Substance into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Anesthetic Agent into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Radioactive Substance into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Destructive Agent into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Insulin into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Other Hormone into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Other Antineoplastic into Muscle, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Muscle, Percutaneous Approach


name: Introduction of Oxazolidinones into Muscle, Percutaneous Approach


name: Introduction of Other Anti-infective into Muscle, Percutaneous Approach


name: Introduction of Anti-inflammatory into Muscle, Percutaneous Approach


name: Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach


name: Introduction of Nutritional Substance into Muscle, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Muscle, Percutaneous Approach


name: Introduction of Anesthetic Agent into Muscle, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Muscle, Percutaneous Approach


name: Introduction of Radioactive Substance into Muscle, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Muscle, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Muscle, Percutaneous Approach


name: Introduction of Destructive Agent into Muscle, Percutaneous Approach


name: Introduction of High-dose Interleukin-2 into Peripheral Vein, Open Approach


name: Introduction of Low-dose Interleukin-2 into Peripheral Vein, Open Approach


name: Introduction of Other Antineoplastic into Peripheral Vein, Open Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Open Approach


name: Introduction of Recombinant Human-activated Protein C into Peripheral Vein, Open


name: Introduction of Other Thrombolytic into Peripheral Vein, Open Approach


name: Introduction of Oxazolidinones into Peripheral Vein, Open Approach


name: Introduction of Other Anti-infective into Peripheral Vein, Open Approach


name: Introduction of Anti-inflammatory into Peripheral Vein, Open Approach


name: Introduction of Serum, Toxoid and Vaccine into Peripheral Vein, Open Approach


name: Introduction of Nutritional Substance into Peripheral Vein, Open Approach


name: Introduction of Electrolytic and Water Balance Substance into Peripheral Vein, Open Approach


name: Introduction of Intracirculatory Anesthetic into Peripheral Vein, Open Approach


name: Introduction of Other Therapeutic Substance into Peripheral Vein, Open Approach


name: Introduction of Blood Brain Barrier Disruption Substance into Peripheral Vein, Open Approach


name: Introduction of Radioactive Substance into Peripheral Vein, Open Approach


name: Introduction of Other Diagnostic Substance into Peripheral Vein, Open Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Vein, Open Approach


name: Introduction of Platelet Inhibitor into Peripheral Vein, Open Approach


name: Introduction of Antiarrhythmic into Peripheral Vein, Open Approach


name: Introduction of Destructive Agent into Peripheral Vein, Open Approach


name: Introduction of Autologous Pancreatic Islet Cells into Peripheral Vein, Open Approach


name: Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Open Approach


name: Introduction of Insulin into Peripheral Vein, Open Approach


name: Introduction of Human B-type Natriuretic Peptide into Peripheral Vein, Open Approach


name: Introduction of Other Hormone into Peripheral Vein, Open Approach


name: Introduction of Immunostimulator into Peripheral Vein, Open


name: Introduction of Immunosuppressive into Peripheral Vein, Open


name: Introduction of Vasopressor into Peripheral Vein, Open Approach


name: Introduction of High-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach


name: Introduction of Low-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach


name: Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Percutaneous Approach


name: Introduction of Recombinant Human-activated Protein C into Peripheral Vein, Percutaneous


name: Introduction of Other Thrombolytic into Peripheral Vein, Percutaneous Approach


name: Introduction of Oxazolidinones into Peripheral Vein, Percutaneous Approach


name: Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach


name: Introduction of Anti-inflammatory into Peripheral Vein, Percutaneous Approach


name: Introduction of Serum, Toxoid and Vaccine into Peripheral Vein, Percutaneous Approach


name: Introduction of Nutritional Substance into Peripheral Vein, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Peripheral Vein, Percutaneous Approach


name: Introduction of Intracirculatory Anesthetic into Peripheral Vein, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Peripheral Vein, Percutaneous Approach


name: Introduction of Blood Brain Barrier Disruption Substance into Peripheral Vein, Percutaneous Approach


name: Introduction of Radioactive Substance into Peripheral Vein, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Peripheral Vein, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Vein, Percutaneous Approach


name: Introduction of Platelet Inhibitor into Peripheral Vein, Percutaneous Approach


name: Introduction of Antiarrhythmic into Peripheral Vein, Percutaneous Approach


name: Introduction of Destructive Agent into Peripheral Vein, Percutaneous Approach


name: Introduction of Autologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach


name: Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach


name: Introduction of Insulin into Peripheral Vein, Percutaneous Approach


name: Introduction of Human B-type Natriuretic Peptide into Peripheral Vein, Percutaneous Approach


name: Introduction of Other Hormone into Peripheral Vein, Percutaneous Approach


name: Introduction of Immunostimulator into Peripheral Vein, Percutaneous


name: Introduction of Immunosuppressive into Peripheral Vein, Percutaneous


name: Introduction of Vasopressor into Peripheral Vein, Percutaneous Approach


name: Introduction of High-dose Interleukin-2 into Central Vein, Open Approach


name: Introduction of Low-dose Interleukin-2 into Central Vein, Open Approach


name: Introduction of Other Antineoplastic into Central Vein, Open Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Open Approach


name: Introduction of Recombinant Human-activated Protein C into Central Vein, Open


name: Introduction of Other Thrombolytic into Central Vein, Open Approach


name: Introduction of Oxazolidinones into Central Vein, Open Approach


name: Introduction of Other Anti-infective into Central Vein, Open Approach


name: Introduction of Anti-inflammatory into Central Vein, Open Approach


name: Introduction of Serum, Toxoid and Vaccine into Central Vein, Open Approach


name: Introduction of Nutritional Substance into Central Vein, Open Approach


name: Introduction of Electrolytic and Water Balance Substance into Central Vein, Open Approach


name: Introduction of Intracirculatory Anesthetic into Central Vein, Open Approach


name: Introduction of Other Therapeutic Substance into Central Vein, Open Approach


name: Introduction of Blood Brain Barrier Disruption Substance into Central Vein, Open Approach


name: Introduction of Radioactive Substance into Central Vein, Open Approach


name: Introduction of Other Diagnostic Substance into Central Vein, Open Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Central Vein, Open Approach


name: Introduction of Platelet Inhibitor into Central Vein, Open Approach


name: Introduction of Antiarrhythmic into Central Vein, Open Approach


name: Introduction of Destructive Agent into Central Vein, Open Approach


name: Introduction of Insulin into Central Vein, Open Approach


name: Introduction of Human B-type Natriuretic Peptide into Central Vein, Open Approach


name: Introduction of Other Hormone into Central Vein, Open Approach


name: Introduction of Immunostimulator into Central Vein, Open


name: Introduction of Immunosuppressive into Central Vein, Open


name: Introduction of Vasopressor into Central Vein, Open Approach


name: Introduction of High-dose Interleukin-2 into Central Vein, Percutaneous Approach


name: Introduction of Low-dose Interleukin-2 into Central Vein, Percutaneous Approach


name: Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Percutaneous Approach


name: Introduction of Recombinant Human-activated Protein C into Central Vein, Percutaneous


name: Introduction of Other Thrombolytic into Central Vein, Percutaneous Approach


name: Introduction of Oxazolidinones into Central Vein, Percutaneous Approach


name: Introduction of Other Anti-infective into Central Vein, Percutaneous Approach


name: Introduction of Anti-inflammatory into Central Vein, Percutaneous Approach


name: Introduction of Serum, Toxoid and Vaccine into Central Vein, Percutaneous Approach


name: Introduction of Nutritional Substance into Central Vein, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Central Vein, Percutaneous Approach


name: Introduction of Intracirculatory Anesthetic into Central Vein, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Central Vein, Percutaneous Approach


name: Introduction of Blood Brain Barrier Disruption Substance into Central Vein, Percutaneous Approach


name: Introduction of Radioactive Substance into Central Vein, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Central Vein, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Central Vein, Percutaneous Approach


name: Introduction of Platelet Inhibitor into Central Vein, Percutaneous Approach


name: Introduction of Antiarrhythmic into Central Vein, Percutaneous Approach


name: Introduction of Destructive Agent into Central Vein, Percutaneous Approach


name: Introduction of Insulin into Central Vein, Percutaneous Approach


name: Introduction of Human B-type Natriuretic Peptide into Central Vein, Percutaneous Approach


name: Introduction of Other Hormone into Central Vein, Percutaneous Approach


name: Introduction of Immunostimulator into Central Vein, Percutaneous


name: Introduction of Immunosuppressive into Central Vein, Percutaneous


name: Introduction of Vasopressor into Central Vein, Percutaneous Approach


name: Introduction of High-dose Interleukin-2 into Peripheral Artery, Open Approach


name: Introduction of Low-dose Interleukin-2 into Peripheral Artery, Open Approach


name: Introduction of Other Antineoplastic into Peripheral Artery, Open Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Open Approach


name: Introduction of Recombinant Human-activated Protein C into Peripheral Artery, Open


name: Introduction of Other Thrombolytic into Peripheral Artery, Open Approach


name: Introduction of Oxazolidinones into Peripheral Artery, Open Approach


name: Introduction of Other Anti-infective into Peripheral Artery, Open Approach


name: Introduction of Anti-inflammatory into Peripheral Artery, Open Approach


name: Introduction of Serum, Toxoid and Vaccine into Peripheral Artery, Open Approach


name: Introduction of Nutritional Substance into Peripheral Artery, Open Approach


name: Introduction of Electrolytic and Water Balance Substance into Peripheral Artery, Open Approach


name: Introduction of Intracirculatory Anesthetic into Peripheral Artery, Open Approach


name: Introduction of Other Therapeutic Substance into Peripheral Artery, Open Approach


name: Introduction of Blood Brain Barrier Disruption Substance into Peripheral Artery, Open Approach


name: Introduction of Radioactive Substance into Peripheral Artery, Open Approach


name: Introduction of Other Diagnostic Substance into Peripheral Artery, Open Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Artery, Open Approach


name: Introduction of Platelet Inhibitor into Peripheral Artery, Open Approach


name: Introduction of Antiarrhythmic into Peripheral Artery, Open Approach


name: Introduction of Destructive Agent into Peripheral Artery, Open Approach


name: Introduction of Insulin into Peripheral Artery, Open Approach


name: Introduction of Human B-type Natriuretic Peptide into Peripheral Artery, Open Approach


name: Introduction of Other Hormone into Peripheral Artery, Open Approach


name: Introduction of Immunostimulator into Peripheral Artery, Open


name: Introduction of Immunosuppressive into Peripheral Artery, Open


name: Introduction of Vasopressor into Peripheral Artery, Open Approach


name: Introduction of High-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach


name: Introduction of Low-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach


name: Introduction of Other Antineoplastic into Peripheral Artery, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Percutaneous Approach


name: Introduction of Recombinant Human-activated Protein C into Peripheral Artery, Percutaneous


name: Introduction of Other Thrombolytic into Peripheral Artery, Percutaneous Approach


name: Introduction of Oxazolidinones into Peripheral Artery, Percutaneous Approach


name: Introduction of Other Anti-infective into Peripheral Artery, Percutaneous Approach


name: Introduction of Anti-inflammatory into Peripheral Artery, Percutaneous Approach


name: Introduction of Serum, Toxoid and Vaccine into Peripheral Artery, Percutaneous Approach


name: Introduction of Nutritional Substance into Peripheral Artery, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Peripheral Artery, Percutaneous Approach


name: Introduction of Intracirculatory Anesthetic into Peripheral Artery, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Peripheral Artery, Percutaneous Approach


name: Introduction of Blood Brain Barrier Disruption Substance into Peripheral Artery, Percutaneous Approach


name: Introduction of Radioactive Substance into Peripheral Artery, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Peripheral Artery, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Artery, Percutaneous Approach


name: Introduction of Platelet Inhibitor into Peripheral Artery, Percutaneous Approach


name: Introduction of Antiarrhythmic into Peripheral Artery, Percutaneous Approach


name: Introduction of Destructive Agent into Peripheral Artery, Percutaneous Approach


name: Introduction of Insulin into Peripheral Artery, Percutaneous Approach


name: Introduction of Human B-type Natriuretic Peptide into Peripheral Artery, Percutaneous Approach


name: Introduction of Other Hormone into Peripheral Artery, Percutaneous Approach


name: Introduction of Immunostimulator into Peripheral Artery, Percutaneous


name: Introduction of Immunosuppressive into Peripheral Artery, Percutaneous


name: Introduction of Vasopressor into Peripheral Artery, Percutaneous Approach


name: Introduction of High-dose Interleukin-2 into Central Artery, Open Approach


name: Introduction of Low-dose Interleukin-2 into Central Artery, Open Approach


name: Introduction of Other Antineoplastic into Central Artery, Open Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Open Approach


name: Introduction of Recombinant Human-activated Protein C into Central Artery, Open


name: Introduction of Other Thrombolytic into Central Artery, Open Approach


name: Introduction of Oxazolidinones into Central Artery, Open Approach


name: Introduction of Other Anti-infective into Central Artery, Open Approach


name: Introduction of Anti-inflammatory into Central Artery, Open Approach


name: Introduction of Serum, Toxoid and Vaccine into Central Artery, Open Approach


name: Introduction of Nutritional Substance into Central Artery, Open Approach


name: Introduction of Electrolytic and Water Balance Substance into Central Artery, Open Approach


name: Introduction of Intracirculatory Anesthetic into Central Artery, Open Approach


name: Introduction of Other Therapeutic Substance into Central Artery, Open Approach


name: Introduction of Blood Brain Barrier Disruption Substance into Central Artery, Open Approach


name: Introduction of Radioactive Substance into Central Artery, Open Approach


name: Introduction of Other Diagnostic Substance into Central Artery, Open Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Central Artery, Open Approach


name: Introduction of Platelet Inhibitor into Central Artery, Open Approach


name: Introduction of Antiarrhythmic into Central Artery, Open Approach


name: Introduction of Destructive Agent into Central Artery, Open Approach


name: Introduction of Insulin into Central Artery, Open Approach


name: Introduction of Human B-type Natriuretic Peptide into Central Artery, Open Approach


name: Introduction of Other Hormone into Central Artery, Open Approach


name: Introduction of Immunostimulator into Central Artery, Open


name: Introduction of Immunosuppressive into Central Artery, Open


name: Introduction of Vasopressor into Central Artery, Open Approach


name: Introduction of High-dose Interleukin-2 into Central Artery, Percutaneous Approach


name: Introduction of Low-dose Interleukin-2 into Central Artery, Percutaneous Approach


name: Introduction of Other Antineoplastic into Central Artery, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Percutaneous Approach


name: Introduction of Recombinant Human-activated Protein C into Central Artery, Percutaneous


name: Introduction of Other Thrombolytic into Central Artery, Percutaneous Approach


name: Introduction of Oxazolidinones into Central Artery, Percutaneous Approach


name: Introduction of Other Anti-infective into Central Artery, Percutaneous Approach


name: Introduction of Anti-inflammatory into Central Artery, Percutaneous Approach


name: Introduction of Serum, Toxoid and Vaccine into Central Artery, Percutaneous Approach


name: Introduction of Nutritional Substance into Central Artery, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Central Artery, Percutaneous Approach


name: Introduction of Intracirculatory Anesthetic into Central Artery, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Central Artery, Percutaneous Approach


name: Introduction of Blood Brain Barrier Disruption Substance into Central Artery, Percutaneous Approach


name: Introduction of Radioactive Substance into Central Artery, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Central Artery, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Central Artery, Percutaneous Approach


name: Introduction of Platelet Inhibitor into Central Artery, Percutaneous Approach


name: Introduction of Antiarrhythmic into Central Artery, Percutaneous Approach


name: Introduction of Destructive Agent into Central Artery, Percutaneous Approach


name: Introduction of Insulin into Central Artery, Percutaneous Approach


name: Introduction of Human B-type Natriuretic Peptide into Central Artery, Percutaneous Approach


name: Introduction of Other Hormone into Central Artery, Percutaneous Approach


name: Introduction of Immunostimulator into Central Artery, Percutaneous


name: Introduction of Immunosuppressive into Central Artery, Percutaneous


name: Introduction of Vasopressor into Central Artery, Percutaneous Approach


name: Introduction of Recombinant Human-activated Protein C into Coronary Artery, Open


name: Introduction of Other Thrombolytic into Coronary Artery, Open Approach


name: Introduction of Other Therapeutic Substance into Coronary Artery, Open Approach


name: Introduction of Other Diagnostic Substance into Coronary Artery, Open Approach


name: Introduction of Platelet Inhibitor into Coronary Artery, Open Approach


name: Introduction of Recombinant Human-activated Protein C into Coronary Artery, Percutaneous


name: Introduction of Other Thrombolytic into Coronary Artery, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Coronary Artery, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Coronary Artery, Percutaneous Approach


name: Introduction of Platelet Inhibitor into Coronary Artery, Percutaneous Approach


name: Introduction of Recombinant Human-activated Protein C into Heart, Open


name: Introduction of Other Thrombolytic into Heart, Open Approach


name: Introduction of Other Therapeutic Substance into Heart, Open Approach


name: Introduction of Other Diagnostic Substance into Heart, Open Approach


name: Introduction of Platelet Inhibitor into Heart, Open Approach


name: Introduction of Recombinant Human-activated Protein C into Heart, Percutaneous


name: Introduction of Other Thrombolytic into Heart, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Heart, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Heart, Percutaneous Approach


name: Introduction of Platelet Inhibitor into Heart, Percutaneous Approach


name: Introduction of Other Antineoplastic into Nose, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Nose, Percutaneous Approach


name: Introduction of Oxazolidinones into Nose, Percutaneous Approach


name: Introduction of Other Anti-infective into Nose, Percutaneous Approach


name: Introduction of Anti-inflammatory into Nose, Percutaneous Approach


name: Introduction of Serum, Toxoid and Vaccine into Nose, Percutaneous Approach


name: Introduction of Anesthetic Agent into Nose, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Nose, Percutaneous Approach


name: Introduction of Radioactive Substance into Nose, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Nose, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Nose, Percutaneous Approach


name: Introduction of Destructive Agent into Nose, Percutaneous Approach


name: Introduction of Other Antineoplastic into Nose, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Nose, Via Natural or Artificial Opening


name: Introduction of Oxazolidinones into Nose, Via Natural or Artificial Opening


name: Introduction of Other Anti-infective into Nose, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Nose, Via Natural or Artificial Opening


name: Introduction of Serum, Toxoid and Vaccine into Nose, Via Natural or Artificial Opening


name: Introduction of Anesthetic Agent into Nose, Via Natural or Artificial Opening


name: Introduction of Other Therapeutic Substance into Nose, Via Natural or Artificial Opening


name: Introduction of Radioactive Substance into Nose, Via Natural or Artificial Opening


name: Introduction of Other Diagnostic Substance into Nose, Via Natural or Artificial Opening


name: Introduction of Analgesics, Hypnotics, Sedatives into Nose, Via Natural or Artificial Opening


name: Introduction of Destructive Agent into Nose, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Nose, External Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Nose, External Approach


name: Introduction of Oxazolidinones into Nose, External Approach


name: Introduction of Other Anti-infective into Nose, External Approach


name: Introduction of Anti-inflammatory into Nose, External Approach


name: Introduction of Serum, Toxoid and Vaccine into Nose, External Approach


name: Introduction of Anesthetic Agent into Nose, External Approach


name: Introduction of Other Therapeutic Substance into Nose, External Approach


name: Introduction of Radioactive Substance into Nose, External Approach


name: Introduction of Other Diagnostic Substance into Nose, External Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Nose, External Approach


name: Introduction of Destructive Agent into Nose, External Approach


name: Introduction of Other Antineoplastic into Bone Marrow, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Bone Marrow, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Bone Marrow, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Ear, Percutaneous Approach


name: Introduction of Other Antineoplastic into Ear, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Ear, Percutaneous Approach


name: Introduction of Oxazolidinones into Ear, Percutaneous Approach


name: Introduction of Other Anti-infective into Ear, Percutaneous Approach


name: Introduction of Anti-inflammatory into Ear, Percutaneous Approach


name: Introduction of Anesthetic Agent into Ear, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Ear, Percutaneous Approach


name: Introduction of Radioactive Substance into Ear, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Ear, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Ear, Percutaneous Approach


name: Introduction of Destructive Agent into Ear, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Ear, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Ear, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Ear, Via Natural or Artificial Opening


name: Introduction of Oxazolidinones into Ear, Via Natural or Artificial Opening


name: Introduction of Other Anti-infective into Ear, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Ear, Via Natural or Artificial Opening


name: Introduction of Anesthetic Agent into Ear, Via Natural or Artificial Opening


name: Introduction of Other Therapeutic Substance into Ear, Via Natural or Artificial Opening


name: Introduction of Radioactive Substance into Ear, Via Natural or Artificial Opening


name: Introduction of Other Diagnostic Substance into Ear, Via Natural or Artificial Opening


name: Introduction of Analgesics, Hypnotics, Sedatives into Ear, Via Natural or Artificial Opening


name: Introduction of Destructive Agent into Ear, Via Natural or Artificial Opening


name: Introduction of Liquid Brachytherapy Radioisotope into Ear, External Approach


name: Introduction of Other Antineoplastic into Ear, External Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Ear, External Approach


name: Introduction of Oxazolidinones into Ear, External Approach


name: Introduction of Other Anti-infective into Ear, External Approach


name: Introduction of Anti-inflammatory into Ear, External Approach


name: Introduction of Anesthetic Agent into Ear, External Approach


name: Introduction of Other Therapeutic Substance into Ear, External Approach


name: Introduction of Radioactive Substance into Ear, External Approach


name: Introduction of Other Diagnostic Substance into Ear, External Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Ear, External Approach


name: Introduction of Destructive Agent into Ear, External Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Eye, Percutaneous Approach


name: Introduction of Other Antineoplastic into Eye, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Eye, Percutaneous Approach


name: Introduction of Oxazolidinones into Eye, Percutaneous Approach


name: Introduction of Other Anti-infective into Eye, Percutaneous Approach


name: Introduction of Anti-inflammatory into Eye, Percutaneous Approach


name: Introduction of Anesthetic Agent into Eye, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Eye, Percutaneous Approach


name: Introduction of Radioactive Substance into Eye, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Eye, Percutaneous Approach


name: Introduction of Pigment into Eye, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Eye, Percutaneous Approach


name: Introduction of Other Gas into Eye, Percutaneous Approach


name: Introduction of Destructive Agent into Eye, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Eye, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Eye, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Eye, Via Natural or Artificial Opening


name: Introduction of Oxazolidinones into Eye, Via Natural or Artificial Opening


name: Introduction of Other Anti-infective into Eye, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Eye, Via Natural or Artificial Opening


name: Introduction of Anesthetic Agent into Eye, Via Natural or Artificial Opening


name: Introduction of Other Therapeutic Substance into Eye, Via Natural or Artificial Opening


name: Introduction of Radioactive Substance into Eye, Via Natural or Artificial Opening


name: Introduction of Other Diagnostic Substance into Eye, Via Natural or Artificial Opening


name: Introduction of Pigment into Eye, Via Natural or Artificial Opening


name: Introduction of Analgesics, Hypnotics, Sedatives into Eye, Via Natural or Artificial Opening


name: Introduction of Other Gas into Eye, Via Natural or Artificial Opening


name: Introduction of Destructive Agent into Eye, Via Natural or Artificial Opening


name: Introduction of Liquid Brachytherapy Radioisotope into Eye, External Approach


name: Introduction of Other Antineoplastic into Eye, External Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Eye, External Approach


name: Introduction of Oxazolidinones into Eye, External Approach


name: Introduction of Other Anti-infective into Eye, External Approach


name: Introduction of Anti-inflammatory into Eye, External Approach


name: Introduction of Anesthetic Agent into Eye, External Approach


name: Introduction of Other Therapeutic Substance into Eye, External Approach


name: Introduction of Radioactive Substance into Eye, External Approach


name: Introduction of Other Diagnostic Substance into Eye, External Approach


name: Introduction of Pigment into Eye, External Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Eye, External Approach


name: Introduction of Other Gas into Eye, External Approach


name: Introduction of Destructive Agent into Eye, External Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Other Antineoplastic into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Oxazolidinones into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Other Anti-infective into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Anti-inflammatory into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Serum, Toxoid and Vaccine into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Nutritional Substance into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Anesthetic Agent into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Radioactive Substance into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Antiarrhythmic into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Destructive Agent into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Oxazolidinones into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Other Anti-infective into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Serum, Toxoid and Vaccine into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Nutritional Substance into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Electrolytic and Water Balance Substance into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Anesthetic Agent into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Other Therapeutic Substance into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Radioactive Substance into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Other Diagnostic Substance into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Analgesics, Hypnotics, Sedatives into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Antiarrhythmic into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Destructive Agent into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Liquid Brachytherapy Radioisotope into Mouth and Pharynx, External Approach


name: Introduction of Other Antineoplastic into Mouth and Pharynx, External Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, External Approach


name: Introduction of Oxazolidinones into Mouth and Pharynx, External Approach


name: Introduction of Other Anti-infective into Mouth and Pharynx, External Approach


name: Introduction of Anti-inflammatory into Mouth and Pharynx, External Approach


name: Introduction of Serum, Toxoid and Vaccine into Mouth and Pharynx, External Approach


name: Introduction of Nutritional Substance into Mouth and Pharynx, External Approach


name: Introduction of Electrolytic and Water Balance Substance into Mouth and Pharynx, External Approach


name: Introduction of Anesthetic Agent into Mouth and Pharynx, External Approach


name: Introduction of Other Therapeutic Substance into Mouth and Pharynx, External Approach


name: Introduction of Radioactive Substance into Mouth and Pharynx, External Approach


name: Introduction of Other Diagnostic Substance into Mouth and Pharynx, External Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Mouth and Pharynx, External Approach


name: Introduction of Antiarrhythmic into Mouth and Pharynx, External Approach


name: Introduction of Destructive Agent into Mouth and Pharynx, External Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Products of Conception, Percutaneous Approach


name: Introduction of Other Antineoplastic into Products of Conception, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Percutaneous Approach


name: Introduction of Oxazolidinones into Products of Conception, Percutaneous Approach


name: Introduction of Other Anti-infective into Products of Conception, Percutaneous Approach


name: Introduction of Anti-inflammatory into Products of Conception, Percutaneous Approach


name: Introduction of Nutritional Substance into Products of Conception, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Products of Conception, Percutaneous Approach


name: Introduction of Anesthetic Agent into Products of Conception, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Products of Conception, Percutaneous Approach


name: Introduction of Radioactive Substance into Products of Conception, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Products of Conception, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Percutaneous Approach


name: Introduction of Other Gas into Products of Conception, Percutaneous Approach


name: Introduction of Destructive Agent into Products of Conception, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Oxazolidinones into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Other Anti-infective into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Nutritional Substance into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Electrolytic and Water Balance Substance into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Anesthetic Agent into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Other Therapeutic Substance into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Radioactive Substance into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Other Diagnostic Substance into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Other Gas into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Destructive Agent into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Liquid Brachytherapy Radioisotope into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Oxazolidinones into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Anti-infective into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anti-inflammatory into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Nutritional Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Electrolytic and Water Balance Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anesthetic Agent into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Therapeutic Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Radioactive Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Diagnostic Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Gas into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Destructive Agent into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Liquid Brachytherapy Radioisotope into Respiratory Tract, Percutaneous Approach


name: Introduction of Other Antineoplastic into Respiratory Tract, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Percutaneous Approach


name: Introduction of Oxazolidinones into Respiratory Tract, Percutaneous Approach


name: Introduction of Other Anti-infective into Respiratory Tract, Percutaneous Approach


name: Introduction of Anti-inflammatory into Respiratory Tract, Percutaneous Approach


name: Introduction of Nutritional Substance into Respiratory Tract, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Respiratory Tract, Percutaneous Approach


name: Introduction of Anesthetic Agent into Respiratory Tract, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Respiratory Tract, Percutaneous Approach


name: Introduction of Radioactive Substance into Respiratory Tract, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Respiratory Tract, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Respiratory Tract, Percutaneous Approach


name: Introduction of Nitric Oxide Gas into Respiratory Tract, Percutaneous Approach


name: Introduction of Other Gas into Respiratory Tract, Percutaneous Approach


name: Introduction of Destructive Agent into Respiratory Tract, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Oxazolidinones into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Other Anti-infective into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Nutritional Substance into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Electrolytic and Water Balance Substance into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Anesthetic Agent into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Other Therapeutic Substance into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Radioactive Substance into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Other Diagnostic Substance into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Analgesics, Hypnotics, Sedatives into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Nitric Oxide Gas into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Other Gas into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Destructive Agent into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Liquid Brachytherapy Radioisotope into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Oxazolidinones into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Anti-infective into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anti-inflammatory into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Nutritional Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Electrolytic and Water Balance Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anesthetic Agent into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Therapeutic Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Radioactive Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Diagnostic Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Analgesics, Hypnotics, Sedatives into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Nitric Oxide Gas into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Gas into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Destructive Agent into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Liquid Brachytherapy Radioisotope into Upper GI, Percutaneous Approach


name: Introduction of Other Antineoplastic into Upper GI, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Percutaneous Approach


name: Introduction of Oxazolidinones into Upper GI, Percutaneous Approach


name: Introduction of Other Anti-infective into Upper GI, Percutaneous Approach


name: Introduction of Anti-inflammatory into Upper GI, Percutaneous Approach


name: Introduction of Nutritional Substance into Upper GI, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Upper GI, Percutaneous Approach


name: Introduction of Anesthetic Agent into Upper GI, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Upper GI, Percutaneous Approach


name: Introduction of Radioactive Substance into Upper GI, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Upper GI, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Upper GI, Percutaneous Approach


name: Introduction of Other Gas into Upper GI, Percutaneous Approach


name: Introduction of Destructive Agent into Upper GI, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Upper GI, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Upper GI, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Via Natural or Artificial Opening


name: Introduction of Oxazolidinones into Upper GI, Via Natural or Artificial Opening


name: Introduction of Other Anti-infective into Upper GI, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Upper GI, Via Natural or Artificial Opening


name: Introduction of Nutritional Substance into Upper GI, Via Natural or Artificial Opening


name: Introduction of Electrolytic and Water Balance Substance into Upper GI, Via Natural or Artificial Opening


name: Introduction of Anesthetic Agent into Upper GI, Via Natural or Artificial Opening


name: Introduction of Other Therapeutic Substance into Upper GI, Via Natural or Artificial Opening


name: Introduction of Radioactive Substance into Upper GI, Via Natural or Artificial Opening


name: Introduction of Other Diagnostic Substance into Upper GI, Via Natural or Artificial Opening


name: Introduction of Analgesics, Hypnotics, Sedatives into Upper GI, Via Natural or Artificial Opening


name: Introduction of Other Gas into Upper GI, Via Natural or Artificial Opening


name: Introduction of Destructive Agent into Upper GI, Via Natural or Artificial Opening


name: Introduction of Liquid Brachytherapy Radioisotope into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Antineoplastic into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Oxazolidinones into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Anti-infective into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anti-inflammatory into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Nutritional Substance into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Electrolytic and Water Balance Substance into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anesthetic Agent into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Therapeutic Substance into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Radioactive Substance into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Diagnostic Substance into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Analgesics, Hypnotics, Sedatives into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Gas into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Destructive Agent into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Liquid Brachytherapy Radioisotope into Lower GI, Percutaneous Approach


name: Introduction of Other Antineoplastic into Lower GI, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Percutaneous Approach


name: Introduction of Oxazolidinones into Lower GI, Percutaneous Approach


name: Introduction of Other Anti-infective into Lower GI, Percutaneous Approach


name: Introduction of Anti-inflammatory into Lower GI, Percutaneous Approach


name: Introduction of Nutritional Substance into Lower GI, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Lower GI, Percutaneous Approach


name: Introduction of Anesthetic Agent into Lower GI, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Lower GI, Percutaneous Approach


name: Introduction of Radioactive Substance into Lower GI, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Lower GI, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Lower GI, Percutaneous Approach


name: Introduction of Other Gas into Lower GI, Percutaneous Approach


name: Introduction of Destructive Agent into Lower GI, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Lower GI, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Via Natural or Artificial Opening


name: Introduction of Oxazolidinones into Lower GI, Via Natural or Artificial Opening


name: Introduction of Other Anti-infective into Lower GI, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Lower GI, Via Natural or Artificial Opening


name: Introduction of Nutritional Substance into Lower GI, Via Natural or Artificial Opening


name: Introduction of Electrolytic and Water Balance Substance into Lower GI, Via Natural or Artificial Opening


name: Introduction of Anesthetic Agent into Lower GI, Via Natural or Artificial Opening


name: Introduction of Other Therapeutic Substance into Lower GI, Via Natural or Artificial Opening


name: Introduction of Radioactive Substance into Lower GI, Via Natural or Artificial Opening


name: Introduction of Other Diagnostic Substance into Lower GI, Via Natural or Artificial Opening


name: Introduction of Analgesics, Hypnotics, Sedatives into Lower GI, Via Natural or Artificial Opening


name: Introduction of Other Gas into Lower GI, Via Natural or Artificial Opening


name: Introduction of Destructive Agent into Lower GI, Via Natural or Artificial Opening


name: Introduction of Liquid Brachytherapy Radioisotope into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Oxazolidinones into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Anti-infective into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anti-inflammatory into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Nutritional Substance into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Electrolytic and Water Balance Substance into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anesthetic Agent into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Therapeutic Substance into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Radioactive Substance into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Diagnostic Substance into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Analgesics, Hypnotics, Sedatives into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Gas into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Destructive Agent into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Other Gas into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Destructive Agent into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Other Gas into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Destructive Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Gas into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Destructive Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Liquid Brachytherapy Radioisotope into Genitourinary Tract, Percutaneous Approach


name: Introduction of Other Antineoplastic into Genitourinary Tract, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Percutaneous Approach


name: Introduction of Oxazolidinones into Genitourinary Tract, Percutaneous Approach


name: Introduction of Other Anti-infective into Genitourinary Tract, Percutaneous Approach


name: Introduction of Anti-inflammatory into Genitourinary Tract, Percutaneous Approach


name: Introduction of Nutritional Substance into Genitourinary Tract, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Genitourinary Tract, Percutaneous Approach


name: Introduction of Anesthetic Agent into Genitourinary Tract, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Genitourinary Tract, Percutaneous Approach


name: Introduction of Radioactive Substance into Genitourinary Tract, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Genitourinary Tract, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Genitourinary Tract, Percutaneous Approach


name: Introduction of Other Gas into Genitourinary Tract, Percutaneous Approach


name: Introduction of Destructive Agent into Genitourinary Tract, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Oxazolidinones into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Other Anti-infective into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Nutritional Substance into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Electrolytic and Water Balance Substance into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Anesthetic Agent into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Other Therapeutic Substance into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Radioactive Substance into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Other Diagnostic Substance into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Analgesics, Hypnotics, Sedatives into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Other Gas into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Destructive Agent into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Liquid Brachytherapy Radioisotope into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Antineoplastic into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Oxazolidinones into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Anti-infective into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anti-inflammatory into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Nutritional Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Electrolytic and Water Balance Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anesthetic Agent into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Therapeutic Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Radioactive Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Diagnostic Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Analgesics, Hypnotics, Sedatives into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Gas into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Destructive Agent into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Adhesion Barrier into Pleural Cavity, Open Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Pleural Cavity, Percutaneous Approach


name: Introduction of Other Antineoplastic into Pleural Cavity, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Percutaneous Approach


name: Introduction of Oxazolidinones into Pleural Cavity, Percutaneous Approach


name: Introduction of Other Anti-infective into Pleural Cavity, Percutaneous Approach


name: Introduction of Anti-inflammatory into Pleural Cavity, Percutaneous Approach


name: Introduction of Nutritional Substance into Pleural Cavity, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Pleural Cavity, Percutaneous Approach


name: Introduction of Anesthetic Agent into Pleural Cavity, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Pleural Cavity, Percutaneous Approach


name: Introduction of Radioactive Substance into Pleural Cavity, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Pleural Cavity, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Pleural Cavity, Percutaneous Approach


name: Introduction of Other Gas into Pleural Cavity, Percutaneous Approach


name: Introduction of Destructive Agent into Pleural Cavity, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Pleural Cavity, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Pleural Cavity, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Via Natural or Artificial Opening


name: Introduction of Other Gas into Pleural Cavity, Via Natural or Artificial Opening


name: Introduction of Adhesion Barrier into Peritoneal Cavity, Open Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Other Antineoplastic into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Oxazolidinones into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Other Anti-infective into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Anti-inflammatory into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Nutritional Substance into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Anesthetic Agent into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Radioactive Substance into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Other Gas into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Destructive Agent into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Peritoneal Cavity, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Peritoneal Cavity, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Via Natural or Artificial Opening


name: Introduction of Other Gas into Peritoneal Cavity, Via Natural or Artificial Opening


name: Introduction of Liquid Brachytherapy Radioisotope into Male Reproductive, Percutaneous Approach


name: Introduction of Other Antineoplastic into Male Reproductive, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Percutaneous Approach


name: Introduction of Oxazolidinones into Male Reproductive, Percutaneous Approach


name: Introduction of Other Anti-infective into Male Reproductive, Percutaneous Approach


name: Introduction of Anti-inflammatory into Male Reproductive, Percutaneous Approach


name: Introduction of Nutritional Substance into Male Reproductive, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Male Reproductive, Percutaneous Approach


name: Introduction of Anesthetic Agent into Male Reproductive, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Male Reproductive, Percutaneous Approach


name: Introduction of Radioactive Substance into Male Reproductive, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Male Reproductive, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Male Reproductive, Percutaneous Approach


name: Introduction of Other Gas into Male Reproductive, Percutaneous Approach


name: Introduction of Destructive Agent into Male Reproductive, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Oxazolidinones into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Other Anti-infective into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Nutritional Substance into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Electrolytic and Water Balance Substance into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Anesthetic Agent into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Other Therapeutic Substance into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Radioactive Substance into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Other Diagnostic Substance into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Analgesics, Hypnotics, Sedatives into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Other Gas into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Destructive Agent into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Liquid Brachytherapy Radioisotope into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Antineoplastic into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Oxazolidinones into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Anti-infective into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anti-inflammatory into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Nutritional Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Electrolytic and Water Balance Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anesthetic Agent into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Therapeutic Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Radioactive Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Diagnostic Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Analgesics, Hypnotics, Sedatives into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Gas into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Destructive Agent into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Adhesion Barrier into Female Reproductive, Open Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Female Reproductive, Percutaneous Approach


name: Introduction of Other Antineoplastic into Female Reproductive, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Percutaneous Approach


name: Introduction of Oxazolidinones into Female Reproductive, Percutaneous Approach


name: Introduction of Other Anti-infective into Female Reproductive, Percutaneous Approach


name: Introduction of Anti-inflammatory into Female Reproductive, Percutaneous Approach


name: Introduction of Nutritional Substance into Female Reproductive, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Female Reproductive, Percutaneous Approach


name: Introduction of Anesthetic Agent into Female Reproductive, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Female Reproductive, Percutaneous Approach


name: Introduction of Radioactive Substance into Female Reproductive, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Female Reproductive, Percutaneous Approach


name: Introduction of Sperm into Female Reproductive, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Female Reproductive, Percutaneous Approach


name: Introduction of Autologous Fertilized Ovum into Female Reproductive, Percutaneous Approach


name: Introduction of Nonautologous Fertilized Ovum into Female Reproductive, Percutaneous Approach


name: Introduction of Other Gas into Female Reproductive, Percutaneous Approach


name: Introduction of Destructive Agent into Female Reproductive, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Oxazolidinones into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Other Anti-infective into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Nutritional Substance into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Electrolytic and Water Balance Substance into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Anesthetic Agent into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Other Therapeutic Substance into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Radioactive Substance into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Other Diagnostic Substance into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Sperm into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Analgesics, Hypnotics, Sedatives into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Autologous Fertilized Ovum into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Nonautologous Fertilized Ovum into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Other Gas into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Destructive Agent into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Liquid Brachytherapy Radioisotope into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Oxazolidinones into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Anti-infective into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anti-inflammatory into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Nutritional Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Electrolytic and Water Balance Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anesthetic Agent into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Therapeutic Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Radioactive Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Diagnostic Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Analgesics, Hypnotics, Sedatives into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Gas into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Destructive Agent into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Embryonic Stem Cells into Cranial Cavity and Brain, Open Approach


name: Introduction of Autologous Somatic Stem Cells into Cranial Cavity and Brain, Open Approach


name: Introduction of Nonautologous Somatic Stem Cells into Cranial Cavity and Brain, Open Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Cranial Cavity and Brain, Percutaneous Approach


name: Introduction of Other Antineoplastic into Cranial Cavity and Brain, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Percutaneous Approach


name: Introduction of Oxazolidinones into Cranial Cavity and Brain, Percutaneous Approach


name: Introduction of Other Anti-infective into Cranial Cavity and Brain, Percutaneous Approach


name: Introduction of Anti-inflammatory into Cranial Cavity and Brain, Percutaneous Approach


name: Introduction of Nutritional Substance into Cranial Cavity and Brain, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Cranial Cavity and Brain, Percutaneous Approach


name: Introduction of Embryonic Stem Cells into Cranial Cavity and Brain, Percutaneous Approach


name: Introduction of Anesthetic Agent into Cranial Cavity and Brain, Percutaneous Approach


name: Introduction of Autologous Somatic Stem Cells into Cranial Cavity and Brain, Percutaneous Approach


name: Introduction of Nonautologous Somatic Stem Cells into Cranial Cavity and Brain, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Cranial Cavity and Brain, Percutaneous Approach


name: Introduction of Radioactive Substance into Cranial Cavity and Brain, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Cranial Cavity and Brain, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Cranial Cavity and Brain, Percutaneous Approach


name: Introduction of Other Gas into Cranial Cavity and Brain, Percutaneous Approach


name: Introduction of Destructive Agent into Cranial Cavity and Brain, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Cranial Cavity and Brain, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Cranial Cavity and Brain, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Via Natural or Artificial Opening


name: Introduction of Other Gas into Cranial Cavity and Brain, Via Natural or Artificial Opening


name: Introduction of Embryonic Stem Cells into Spinal Canal, Open Approach


name: Introduction of Autologous Somatic Stem Cells into Spinal Canal, Open Approach


name: Introduction of Nonautologous Somatic Stem Cells into Spinal Canal, Open Approach


name: Introduction of High-dose Interleukin-2 into Spinal Canal, Percutaneous Approach


name: Introduction of Low-dose Interleukin-2 into Spinal Canal, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Spinal Canal, Percutaneous Approach


name: Introduction of Other Antineoplastic into Spinal Canal, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Spinal Canal, Percutaneous Approach


name: Introduction of Oxazolidinones into Spinal Canal, Percutaneous Approach


name: Introduction of Other Anti-infective into Spinal Canal, Percutaneous Approach


name: Introduction of Anti-inflammatory into Spinal Canal, Percutaneous Approach


name: Introduction of Nutritional Substance into Spinal Canal, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Spinal Canal, Percutaneous Approach


name: Introduction of Embryonic Stem Cells into Spinal Canal, Percutaneous Approach


name: Introduction of Anesthetic Agent into Spinal Canal, Percutaneous Approach


name: Introduction of Autologous Somatic Stem Cells into Spinal Canal, Percutaneous Approach


name: Introduction of Nonautologous Somatic Stem Cells into Spinal Canal, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Spinal Canal, Percutaneous Approach


name: Introduction of Radioactive Substance into Spinal Canal, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Spinal Canal, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Spinal Canal, Percutaneous Approach


name: Introduction of Other Gas into Spinal Canal, Percutaneous Approach


name: Introduction of Destructive Agent into Spinal Canal, Percutaneous Approach


name: Introduction of Other Gas into Spinal Canal, Via Natural or Artificial Opening


name: Introduction of High-dose Interleukin-2 into Epidural Space, Percutaneous Approach


name: Introduction of Low-dose Interleukin-2 into Epidural Space, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Epidural Space, Percutaneous Approach


name: Introduction of Other Antineoplastic into Epidural Space, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Epidural Space, Percutaneous Approach


name: Introduction of Oxazolidinones into Epidural Space, Percutaneous Approach


name: Introduction of Other Anti-infective into Epidural Space, Percutaneous Approach


name: Introduction of Anti-inflammatory into Epidural Space, Percutaneous Approach


name: Introduction of Nutritional Substance into Epidural Space, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Epidural Space, Percutaneous Approach


name: Introduction of Anesthetic Agent into Epidural Space, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Epidural Space, Percutaneous Approach


name: Introduction of Radioactive Substance into Epidural Space, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Epidural Space, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Epidural Space, Percutaneous Approach


name: Introduction of Other Gas into Epidural Space, Percutaneous Approach


name: Introduction of Destructive Agent into Epidural Space, Percutaneous Approach


name: Introduction of Other Gas into Epidural Space, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Peripheral Nerves and Plexi, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Peripheral Nerves and Plexi, Percutaneous Approach


name: Introduction of Destructive Agent into Peripheral Nerves and Plexi, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Joints, Percutaneous Approach


name: Introduction of Other Antineoplastic into Joints, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Joints, Percutaneous Approach


name: Introduction of Oxazolidinones into Joints, Percutaneous Approach


name: Introduction of Other Anti-infective into Joints, Percutaneous Approach


name: Introduction of Anti-inflammatory into Joints, Percutaneous Approach


name: Introduction of Nutritional Substance into Joints, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Joints, Percutaneous Approach


name: Introduction of Anesthetic Agent into Joints, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Joints, Percutaneous Approach


name: Introduction of Radioactive Substance into Joints, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Joints, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Joints, Percutaneous Approach


name: Introduction of Other Gas into Joints, Percutaneous Approach


name: Introduction of Destructive Agent into Joints, Percutaneous Approach


name: Introduction of Other Antineoplastic into Bones, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Bones, Percutaneous Approach


name: Introduction of Oxazolidinones into Bones, Percutaneous Approach


name: Introduction of Other Anti-infective into Bones, Percutaneous Approach


name: Introduction of Anti-inflammatory into Bones, Percutaneous Approach


name: Introduction of Nutritional Substance into Bones, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Bones, Percutaneous Approach


name: Introduction of Anesthetic Agent into Bones, Percutaneous Approach


name: Introduction of Recombinant Bone Morphogenetic Protein into Bones, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Bones, Percutaneous Approach


name: Introduction of Radioactive Substance into Bones, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Bones, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Bones, Percutaneous Approach


name: Introduction of Destructive Agent into Bones, Percutaneous Approach


name: Introduction of Other Antineoplastic into Lymphatics, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Lymphatics, Percutaneous Approach


name: Introduction of Oxazolidinones into Lymphatics, Percutaneous Approach


name: Introduction of Other Anti-infective into Lymphatics, Percutaneous Approach


name: Introduction of Anti-inflammatory into Lymphatics, Percutaneous Approach


name: Introduction of Nutritional Substance into Lymphatics, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Lymphatics, Percutaneous Approach


name: Introduction of Anesthetic Agent into Lymphatics, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Lymphatics, Percutaneous Approach


name: Introduction of Radioactive Substance into Lymphatics, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Lymphatics, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Lymphatics, Percutaneous Approach


name: Introduction of Destructive Agent into Lymphatics, Percutaneous Approach


name: Introduction of Anti-inflammatory into Cranial Nerves, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Cranial Nerves, Percutaneous Approach


name: Introduction of Destructive Agent into Cranial Nerves, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Pericardial Cavity, Percutaneous Approach


name: Introduction of Other Antineoplastic into Pericardial Cavity, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Pericardial Cavity, Percutaneous Approach


name: Introduction of Oxazolidinones into Pericardial Cavity, Percutaneous Approach


name: Introduction of Other Anti-infective into Pericardial Cavity, Percutaneous Approach


name: Introduction of Anti-inflammatory into Pericardial Cavity, Percutaneous Approach


name: Introduction of Nutritional Substance into Pericardial Cavity, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Pericardial Cavity, Percutaneous Approach


name: Introduction of Anesthetic Agent into Pericardial Cavity, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Pericardial Cavity, Percutaneous Approach